Transcriptome analysis of normal-appearing white matter reveals cortisol- and disease-associated gene expression profiles in multiple sclerosis

Multiple Sclerosis

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis

Neurology.

Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T

doi: 10.1212/WNL.

Multiple Sclerosis

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis

Sci Rep.

Friess J, Hecker M, Roch L, Koczan D, Fitzner B, Angerer IC, Schröder I, Flechtner K, Thiesen HJ, Winkelmann A, Zettl UK

doi: 10.1038/srep42087.

Multiple Sclerosis

T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter

Sci Rep.

Kelemen P, Alaoui J, Sieron D, Chan A, Kamm CP, Heldner MR, Gralla J, Wiest R, Verma RK

doi: 10.1038/s41598-018-

Multiple Sclerosis

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis

Ther Adv Neurol Disord.

Prosperini L, Kinkel RP, Miravalle AA, Iaffaldano P, Fantaccini S

doi: 10.1177/

Multiple Sclerosis

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study

Lancet Neurol.

Trapp BD, Vignos M, Dudman J, Chang A, Fisher E, Staugaitis SM, Battapady H, Mork S, Ontaneda D, Jones SE, Fox RJ, Chen J, Nakamura K, Rudick RA

doi: 10.1016/S1474-4422

Amyotrophic Lateral Sclerosis

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes

JAMA Neurol.

Zhao W, Beers DR, Hooten KG, Sieglaff DH, Zhang A, Kalyana-Sundaram S, Traini CM, Halsey WS, Hughes AM, Sathe GM, Livi GP, Fan GH, Appel SH

doi: 10.1001/

Multiple Sclerosis

Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

Brain.

Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL

doi: 10.1093/brain/awz212.

SPECIAL REPORT

Multiple Sclerosis

Vaccination Readiness in Multiple Sclerosis

COMMENTED

Multiple SclerosisAnxiety and Depression

The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?

Mult Scler Relat Disord.

Barin L, Salmen A, Disanto G, Babačić H, Calabrese P, Chan A, Kamm CP, Kesselring J, Kuhle J, Gobbi C, Pot C, Puhan MA, von Wyl V, Swiss Multiple Sclerosis Registry (SMSR)

doi: 10.1016/j.msard.2018.07.013.

Related content

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis

T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes

Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

Vaccination Readiness in Multiple Sclerosis

The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?